Curcumin down-regulates visfatin expression and inhibits breast cancer cell invasion

Endocrinology

Volumn 153, Issue 2, 2012, Pages 554-563

  Kim, Su Ryun ^a   Park, Hyun Joo ^a   Bae, Yun Hee ^a   Ahn, Soon Cheol ^b   Wee, Hee Jun ^c   Yun, Il ^a   Jang, Hye Ock ^a   Bae, Moon Kyoung ^a   Bae, Soo Kyung ^a  

^a Pusan National University   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; SMALL INTERFERING RNA; SYNAPTOTAGMIN I;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL INVASION; CELL STRAIN MCF 7; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL LINE, TUMOR; CURCUMIN; CYTOKINES; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; NF-KAPPA B; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY; PROMOTER REGIONS, GENETIC; RESPONSE ELEMENTS;

EID: 84862972274     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1413     Document Type: Article

References (30)

1. McSherry EA, Donatello S, Hopkins AM, McDonnell S 2007 Molecular basis of invasion in breast cancer. Cell Mol Life Sci 64:3201-3218
2. Mego M, Mani SA, Cristofanilli M 2010 Molecular mechanisms of metastasis in breast cancer: clinical applications. Nat Rev Clin Oncol 7:693-701
3. Brown KA, Simpson ER 2010 Obesity and breast cancer: progress to understanding the relationship. Cancer Res 70:4-7
4. Grossmann ME, Ray A, Nkhata KJ, Malakhov DA, Rogozina OP, Dogan S, Cleary MP 2010 Obesity and breast cancer: status of leptin and adiponectin in pathological processes. Cancer Metastasis Rev 29:641-653
5. Surmacz E 2007 Obesity hormone leptin: a new target in breast cancer? Breast Cancer Res 9:301
6. Jardé T, Perrier S, Vasson MP, Caldefie-Chézet F 2011 Molecular mechanisms of leptin and adiponectin in breast cancer. Eur J Cancer 47:33-43
7. Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I 1994 Cloning and characterization of the cDNA encoding a novel human pre-Bcell colony-enhancing factor. Mol Cell Biol 14:1431-1437
8. Sonoli SS, Shivprasad S, Prasad CV, Patil AB, Desai PB, Somannavar MS 2011 Visfatin: a review. Eur Rev Med Pharmacol Sci 15:9-14
9. Kitani T, Okuno S, Fujisawa H 2003 Growth phase-dependent changes in the subcellular localization of pre-B-cell colony-enhancing factor. FEBS Lett 544:74-78 (Pubitemid 36628039)
10. Kim SR, Bae YH, Bae SK, Choi KS, Yoon KH, Koo TH, Jang HO, Yun I, Kim KW, Kwon YG, Yoo MA, Bae MK 2008 Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-κB activation in endothelial cells. Biochim Biophys Acta 1783: 886-895
11. Kim SR, Bae SK, Choi KS, Park SY, Jun HO, Lee JY, Jang HO, Yun I, Yoon KH, Kim YJ, Yoo MA, Kim KW, Bae MK 2007 Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2. Biochem Biophys Res Commun 357:150-156 (Pubitemid 46574511)
12. Bae YH, Park HJ, Kim SR, Kim JY, Kang Y, Kim JA, Wee HJ, Kageyama R, Jung JS, Bae MK, Bae SK 2011 Notch1 mediates visfatin-induced FGF-2 up-regulation and endothelial angiogenesis. Cardiovasc Res 89:436-445
13. Bi TQ, Che XM 2010 Nampt/PBEF/visfatin and cancer. Cancer Biol Ther 10:119-125
14. Nakajima TE, Yamada Y, Hamano T, Furuta K, Gotoda T, Katai H, Kato K, Hamaguchi T, Shimada Y 2009 Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer. J Gastroenterol 44:685-690
15. Wang B, Hasan MK, Alvarado E, Yuan H, Wu H, Chen WY 2011 NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response. Oncogene 30:907-921
16. Bae SK, Kim SR, Kim JG, Kim JY, Koo TH, Jang HO, Yun I, Yoo MA, Bae MK 2006 Hpoxic induction of human visfatin gene is directly mediated by hypoxia-inducible factor-1. FEBS Lett 580: 4105-4113 (Pubitemid 44037574)
17. Folgueira MA, Carraro DM, Brentani H, Patrão DF, Barbosa EM, Netto MM, Caldeira JR, Katayama ML, Soares FA, Oliveira CT, Reis LF, Kaiano JH, Camargo LP, Vêncio RZ, Snitcovsky IM, Makdissi FB, e Silva PJ, Gó es JC, Brentani MM 2005 Gene expression profile associated with response to doxorubicin-based therapy in breast cancer. Clin Cancer Res 11:7434-7443
18. Kim JG, Kim EO, Jeong BR, Min YJ, Park JW, Kim ES, Namgoong IS, Kim YI, Lee BJ 2010 Visfatin stimulates proliferation of MCF-7 human breast cancer cells. Mol Cells 30:341-345
19. Menon VP, Sudheer AR 2007 Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol 595:105-125
20. Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, Price JE 2005 Curcumin suppresses the paclitaxel- induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11:7490-7498 (Pubitemid 41507710)
21. Kunnumakkara AB, Anand P, Aggarwal BB 2008 Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269:199-225
22. Bachmeier BE, Mohrenz IV, Mirisola V, Schleicher E, Romeo F, Höhneke C, Jochum M, Nerlich AG, Pfeffer U 2008 Curcumin down-regulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFκB. Carcinogenesis 29:779-789 (Pubitemid 351494166)
23. Kendal CE, Bryant-Greenwood GD 2007 Pre-B-cell colony-enhancing factor (PBEF/Visfatin) gene expression is modulated by NF-κB and AP-1 in human amniotic epithelial cells. Placenta 28:305-314 (Pubitemid 46505934)
24. Narasimhan M, Ammanamanchi S 2008 Curcumin blocks RON tyrosine kinase-mediated invasion of breast carcinoma cells. Cancer Res 68:5185-5192
25. Moschen AR, Gerner RR, Tilg H 2010 Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders. Curr Pharm Des 16:1913-1920
26. Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U 1995 Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485-8148
27. Su CC, Chen GW, Lin JG, Wu LT, Chung JG 2006 Curcumin inhibits cell migration of human colon cancer colo 205 cells through the inhibition of nuclear factor κB /p65 and down-regulates cyclooxygenase- 2 and matrix metalloproteinase-2 expressions. Anticancer Res 26:1281-1288
28. Wu JT, Kral JG 2005 The NF-κB/IκB signaling system: a molecular target in breast cancer therapy. J Surg Res 123:158-169 (Pubitemid 40094658)
29. Yamamoto Y, Ibusuki M, Okumura Y, Kawasoe T, Kai K, Iyama K, Iwase H 2008 Hypoxia-inducible factor 1α is closely linked to an aggressive phenotype in breast cancer. Breast Cancer Res Treat 110: 465-475 (Pubitemid 351962589)
30. Wanecq E, Prévot D, Carpéné C 2009 Lack of direct insulin-like action of visfatin/Nampt/PBEF1 in human adipocytes. J Physiol Biochem 65:351-359